Foundation Medicine Inc (FMI) financial statements (2022 and earlier)

Company profile

Business Address 150 SECOND STREET
CAMBRIDGE, MA 02141
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments71,404143,019207,37072,080124,293
Cash and cash equivalents71,40463,617117,76372,080124,293
Short-term investments 79,40289,607  
Receivables30,12610,2137,7659,8946,262
Inventory, net of allowances, customer advances and progress billings13,17110,4387,9924,8091,763
Inventory13,17110,4387,9924,8091,763
Other undisclosed current assets9,1185,2516,5172,865992
Total current assets:123,819168,921229,64489,648133,310
Noncurrent Assets
Property, plant and equipment41,11941,48641,33321,01522,104
Long-term investments and receivables  24,939  
Long-term investments  24,939  
Restricted cash and investments2,3051,3951,3958641,725
Other noncurrent assets1,7602,233678411129
Total noncurrent assets:45,18445,11468,34522,29023,958
TOTAL ASSETS:169,003214,035297,989111,938157,268
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities58,67132,47623,29119,68815,433
Accounts payable21,92611,89810,4697,2637,007
Accrued liabilities36,74520,57812,8227,4145,168
Employee-related liabilities   5,0113,258
Debt    1,499
Deferred revenue and credits4,0304,4282,8631,7692,085
Other undisclosed current liabilities3,7423,7473,742(5,011)(3,258)
Total current liabilities:66,44340,65129,89616,44615,759
Noncurrent Liabilities
Liabilities, other than long-term debt60,000  9,3159,710
Deferred revenue and credits   9,3159,710
Due to related parties60,000    
Total noncurrent liabilities:60,000  9,3159,710
Total liabilities:126,44340,65129,89625,76125,469
Stockholders' equity
Stockholders' equity attributable to parent31,668164,846257,68986,169131,711
Common stock44333
Additional paid in capital537,904509,664489,480228,151221,471
Accumulated other comprehensive income (loss)109(14)(178)  
Accumulated deficit(506,349)(344,808)(231,616)(141,985)(89,763)
Total stockholders' equity:31,668164,846257,68986,169131,711
Other undisclosed liabilities and equity10,8928,53810,404888
TOTAL LIABILITIES AND EQUITY:169,003214,035297,989111,938157,268

Income statement (P&L) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues152,903116,86593,20361,07928,990
Revenue, net 116,86593,203858854
Cost of revenue(67,080)(52,978)(36,695)(27,434)(11,659)
Gross profit:85,82363,88756,50833,64517,331
Operating expenses(246,766)(173,933)(143,527)(95,123)(64,537)
Other undisclosed operating income (loss) (3,770)(2,736)8,1955,445
Operating loss:(160,943)(113,816)(89,755)(53,283)(41,761)
Nonoperating income (expense)2046241241,061(1,183)
Other nonoperating income (expense)204  1,103(948)
Interest and debt expense(283)    
Net loss:(161,022)(113,192)(89,631)(52,222)(42,944)
Other undisclosed net loss attributable to parent(444)    
Net loss attributable to parent:(161,466)(113,192)(89,631)(52,222)(42,944)
Preferred stock dividends and other adjustments    (139)
Net loss available to common stockholders, diluted:(161,466)(113,192)(89,631)(52,222)(43,083)

Comprehensive Income ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(161,022)(113,192)(89,631)(52,222)(42,944)
Other comprehensive income (loss)123164(178)  
Comprehensive loss:(160,899)(113,028)(89,809)(52,222)(42,944)
Other undisclosed comprehensive loss, net of tax, attributable to parent(444)    
Comprehensive loss, net of tax, attributable to parent:(161,343)(113,028)(89,809)(52,222)(42,944)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: